RESTON, Va., Oct. 10, 2019 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology leader, has been awarded a follow-on contract by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) within the National Institutes of Health (NIH) to provide a wide range of software development services in support of the Office of Extramural Research (OER). The single award, cost-plus-fixed-fee contract has a one-year base period of performance followed by four one-year option periods, and an approximate value of $150 million, if all options are exercised. Work will be performed in Bethesda, MD.
The OER provides vital solutions to manage the receipt, processing, review, award reporting and monitoring of more than $30 billion in research and non-research grants awarded annually to improve human health through biomedical research and public health services. OER systems are used by applicants and grantees at more than 38,000 institutions worldwide.
Under the contract, Leidos will provide software development services including design, development, and application testing services following the eRA Agile software development lifecycle. Leidos' use of automation and artificial intelligence (AI) will continue to increase efficiency and drive down maintenance costs for OER.
"Since 2008, Leidos has provided OER with eRA Software Development Support Services to enhance its framework for research administration, scientific integrity, and public accountability," said Jon Scholl, Leidos Health Group president. "This follow-on award is a testament to our innovative software development approach and seamless technical support for a customer that is critical to the biomedical research community."
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Va., Leidos reported annual revenues of approximately $10.19 billion for the fiscal year ended December 28, 2018. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended December 28, 2018, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.